REQUEST A DEMO
Total
USD $0.00
Search more companies

Xenico Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Miscellaneous Durable Goods Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Department Stores | Advertising Agencies | Management of Companies and Enterprises
Full name: Xenico Pharma Sp. z o.o. Profile Updated: April 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Xenico Pharma Sp. z o.o. is based in Poland. The head office is in Wroclaw. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on May 20, 2015. It currently has a total number of 1 (2015) employees. There was a net sales revenue increase of 2.14% reported in Xenico Pharma Sp. z o.o.’s latest financial highlights for 2023. There was a total growth of 22.79% in Xenico Pharma Sp. z o.o.’s total assets over the same period. Xenico Pharma Sp. z o.o.’s net profit margin increased by 2.14% in 2023.

Headquarters
Ul. Bialowieska 91B
Wroclaw; Dolnoslaskie; Postal Code: 54-234

Contact Details: Purchase the Xenico Pharma Sp. z o.o. report to view the information.

Website: http://xenico.pl/

Basic Information
Total Employees:
Purchase the Xenico Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Xenico Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Xenico Pharma Sp. z o.o. report to view the information.
Incorporation Date:
May 20, 2015
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Xenico Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
2.14%
Total operating revenue
1.79%
Operating profit (EBIT)
284.95%
EBITDA
243.02%
Net Profit (Loss) for the Period
346.69%
Total assets
22.79%
Total equity
11.75%
Operating Profit Margin (ROS)
2.89%
Net Profit Margin
2.14%
Return on Equity (ROE)
7.88%
Debt to Equity Ratio
-3.21%
Quick Ratio
-0.1%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?